146 related articles for article (PubMed ID: 12923910)
1. Patient management scenario: a framework for clinical decision and prognosis.
Gospodarowicz M; O'Sullivan B
Semin Surg Oncol; 2003; 21(1):8-12. PubMed ID: 12923910
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic factors in malignant tumors--significance for quality management].
Hermanek P
Z Arztl Fortbild Qualitatssich; 1997 Jun; 91(3):289-92. PubMed ID: 9312435
[TBL] [Abstract][Full Text] [Related]
3. Patterns of failure and outcome in esthesioneuroblastoma.
Dias FL; Sa GM; Lima RA; Kligerman J; Leoncio MP; Freitas EQ; Soares JR; Arcuri RA
Arch Otolaryngol Head Neck Surg; 2003 Nov; 129(11):1186-92. PubMed ID: 14623748
[TBL] [Abstract][Full Text] [Related]
4. Estimating cancer survival and clinical outcome based on genetic tumor progression scores.
Rahnenführer J; Beerenwinkel N; Schulz WA; Hartmann C; von Deimling A; Wullich B; Lengauer T
Bioinformatics; 2005 May; 21(10):2438-46. PubMed ID: 15705654
[TBL] [Abstract][Full Text] [Related]
5. To what extent do cancer patients use complementary and alternative medicine?
Deng G; Cassileth BR
Nat Clin Pract Oncol; 2005 Oct; 2(10):496-7. PubMed ID: 16205766
[No Abstract] [Full Text] [Related]
6. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in cancer.
Gospodarowicz M; O'Sullivan B
Semin Surg Oncol; 2003; 21(1):13-8. PubMed ID: 12923911
[TBL] [Abstract][Full Text] [Related]
8. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
9. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.
Shaha AR
Laryngoscope; 2004 Mar; 114(3):393-402. PubMed ID: 15091208
[TBL] [Abstract][Full Text] [Related]
10. Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women.
Pentheroudakis G; Fountzilas G; Bafaloukos D; Koutsoukou V; Pectasides D; Skarlos D; Samantas E; Kalofonos HP; Gogas H; Pavlidis N
Breast Cancer Res Treat; 2006 Jun; 97(3):237-44. PubMed ID: 16322882
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing change of preoperative treatment intent in a gastrointestinal cancer practice.
Schwarz RE
World J Surg Oncol; 2007 Mar; 5():32. PubMed ID: 17355626
[TBL] [Abstract][Full Text] [Related]
12. [Clinical prediction in medical oncology].
González Barón M
An R Acad Nac Med (Madr); 2003; 120(1):135-51; discussion 151-3. PubMed ID: 14560556
[TBL] [Abstract][Full Text] [Related]
13. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
[TBL] [Abstract][Full Text] [Related]
14. Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression.
Lu L; Katsaros D; Wiley A; de la Longrais IA; Puopolo M; Yu H
Cancer Invest; 2008 Mar; 26(2):185-92. PubMed ID: 18259951
[TBL] [Abstract][Full Text] [Related]
15. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
[TBL] [Abstract][Full Text] [Related]
16. Assessing 2-month clinical prognosis in hospitalized patients with advanced solid tumors.
Barbot AC; Mussault P; Ingrand P; Tourani JM
J Clin Oncol; 2008 May; 26(15):2538-43. PubMed ID: 18487571
[TBL] [Abstract][Full Text] [Related]
17. Management and outcomes of isolated axillary node recurrence in breast cancer.
Konkin DE; Tyldesley S; Kennecke H; Speers CH; Olivotto IA; Davis N
Arch Surg; 2006 Sep; 141(9):867-72; discussion 872-4. PubMed ID: 16983030
[TBL] [Abstract][Full Text] [Related]
18. Sarcoma of the prostate: a single institutional review.
Janet NL; May AW; Akins RS
Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120
[TBL] [Abstract][Full Text] [Related]
19. Design and endpoints of clinical trials in hepatocellular carcinoma.
Llovet JM; Di Bisceglie AM; Bruix J; Kramer BS; Lencioni R; Zhu AX; Sherman M; Schwartz M; Lotze M; Talwalkar J; Gores GJ;
J Natl Cancer Inst; 2008 May; 100(10):698-711. PubMed ID: 18477802
[TBL] [Abstract][Full Text] [Related]
20. Personalized medical treatment strategies for patients with chronic myeloid leukemia.
Burton C; Marin D; Apperley J
Expert Rev Anticancer Ther; 2005 Apr; 5(2):343-53. PubMed ID: 15877530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
